HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,000 | +45.5% | 15,221 | +65.5% | 0.00% | – |
| Q2 2023 | $11,000 | -38.9% | 9,195 | -20.4% | 0.00% | – |
| Q1 2023 | $18,000 | -58.1% | 11,550 | -32.3% | 0.00% | – |
| Q4 2022 | $43,000 | +72.0% | 17,070 | +180.9% | 0.00% | – |
| Q3 2022 | $25,000 | 0.0% | 6,077 | -29.2% | 0.00% | – |
| Q2 2022 | $25,000 | -85.8% | 8,584 | -72.2% | 0.00% | – |
| Q1 2022 | $176,000 | -53.2% | 30,828 | -25.1% | 0.00% | – |
| Q4 2021 | $376,000 | +29.7% | 41,176 | +51.8% | 0.00% | – |
| Q3 2021 | $290,000 | -17.8% | 27,117 | +19.2% | 0.00% | – |
| Q2 2021 | $353,000 | -11.3% | 22,747 | -7.5% | 0.00% | – |
| Q1 2021 | $398,000 | +1.8% | 24,582 | +33.1% | 0.00% | – |
| Q4 2020 | $391,000 | +33.9% | 18,464 | -6.3% | 0.00% | – |
| Q3 2020 | $292,000 | +9.4% | 19,695 | +8.0% | 0.00% | – |
| Q2 2020 | $267,000 | -5.0% | 18,236 | -23.9% | 0.00% | – |
| Q1 2020 | $281,000 | -75.6% | 23,960 | -51.1% | 0.00% | – |
| Q4 2019 | $1,151,000 | +249.8% | 49,022 | +176.3% | 0.00% | – |
| Q3 2019 | $329,000 | -44.3% | 17,740 | -44.2% | 0.00% | – |
| Q2 2019 | $591,000 | +93.8% | 31,767 | +154.6% | 0.00% | – |
| Q1 2019 | $305,000 | +400.0% | 12,477 | +428.2% | 0.00% | – |
| Q4 2018 | $61,000 | -52.3% | 2,362 | -41.6% | 0.00% | – |
| Q3 2018 | $128,000 | +28.0% | 4,046 | +55.9% | 0.00% | – |
| Q2 2018 | $100,000 | +1566.7% | 2,596 | +1142.1% | 0.00% | – |
| Q1 2018 | $6,000 | -91.5% | 209 | -94.7% | 0.00% | – |
| Q4 2017 | $71,000 | -29.7% | 3,929 | -37.1% | 0.00% | – |
| Q3 2017 | $101,000 | +4950.0% | 6,251 | +3392.2% | 0.00% | – |
| Q2 2017 | $2,000 | -100.0% | 179 | -100.0% | 0.00% | -100.0% |
| Q1 2017 | $5,640,000 | +4.4% | 375,968 | -8.8% | 0.00% | 0.0% |
| Q4 2016 | $5,402,000 | -25.0% | 412,461 | -1.3% | 0.00% | -25.0% |
| Q3 2016 | $7,200,000 | – | 417,900 | +2611775.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 16 | -90.8% | 0.00% | – |
| Q4 2015 | $5,000 | -85.7% | 174 | -87.9% | 0.00% | – |
| Q3 2015 | $35,000 | – | 1,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |